Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 17 04:00PM ET
5.39
Dollar change
+0.08
Percentage change
1.51
%
IndexRUT P/E- EPS (ttm)- Insider Own25.36% Shs Outstand28.23M Perf Week12.76%
Market Cap192.53M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float26.66M Perf Month-24.19%
Income- PEG- EPS next Q-0.09 Inst Own1.72% Short Float0.86% Perf Quarter-50.96%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.95 Perf Half Y-
Book/sh-0.12 P/B- EPS next Y- ROA- Short Interest0.23M Perf Year-
Cash/sh0.23 P/C23.59 EPS next 5Y- ROE- 52W Range3.90 - 55.00 Perf YTD-81.48%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-90.20% Beta-
Dividend TTM- Quick Ratio0.64 Sales past 5Y0.00% Gross Margin- 52W Low38.21% ATR (14)0.93
Dividend Ex-Date- Current Ratio0.64 EPS Y/Y TTM- Oper. Margin- RSI (14)44.72 Volatility7.36% 20.59%
Employees10 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-437.63% Payout- Rel Volume0.51 Prev Close5.31
Sales Surprise- EPS Surprise- Sales Q/Q- EarningsMay 29 Avg Volume240.96K Price5.39
SMA208.66% SMA50-32.53% SMA200-45.90% Trades Volume123,390 Change1.51%
Jul-15-24 09:31AM
Jun-25-24 09:31AM
Jun-13-24 09:31AM
Jun-06-24 09:31AM
May-15-24 04:30PM
09:54AM Loading…
09:54AM
May-14-24 05:24PM
May-07-24 09:31AM
Apr-25-24 08:00AM
Apr-11-24 09:31AM
Apr-04-24 09:31AM
Mar-28-24 09:31AM
Mar-19-24 09:31AM
Mar-13-24 09:31AM
Mar-06-24 09:31AM
05:44PM Loading…
Feb-29-24 05:44PM
Feb-20-24 09:31AM
Feb-13-24 09:31AM
Feb-08-24 09:31AM
Feb-06-24 09:31AM
Jan-31-24 10:00AM
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm's product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O'Heeron on April 8, 2021 and is headquartered in Houston, TX.